Reaffirming revenue guidance, especially in a range as substantial as $2.810 billion to $2.850 billion, signals to investors that Exact Sciences is confident in its operational stability and growth prospects. This positive outlook is likely to foster investor confidence, potentially leading to a short-term positive impact on the stock price.